OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation.
Overview
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
- Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou, China
- The First School of Medicine and School of Information and Engineering, Wenzhou Medical University, Wenzhou, China
- Department of Rehabilitation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany
- Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Abstract
Microglia contribute to detrimental neuroinflammation under pathological conditions and thereby drive the pathogenesis and development of various diseases of the central nervous system (CNS). Here, the deubiquitinating enzyme OTUB1 is identified as a regulator of microglial activation and CNS inflammation. In mice, microglia-specific OTUB1 deletion significantly ameliorates ischemic brain injury by reducing the pro-inflammatory activation of microglia. OTUB1 enhances Toll-like receptor (TLR) signaling through stabilizing UBC13 and TAB2, leading to the increased induction of cytokines. Notably, OTUB1 reduces the proteasomal degradation of TAB2 by reducing its K48 ubiquitination in a catalytic activity-independent manner. Moreover, microglia-confined OTUB1 deficiency also alleviates lipopolysaccharide-induc
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE16561, at NCBI GEO; found in the text, “Genetic inhibition of microglial OTUB1 reduces…”
Other data links
- ebi.ac.uk/
biostudies/ , EMBL-EBI; found in the text, “Author contributions”sourcedata
Data availability
This study contains no data deposited in external repositories.
The source data of this paper are collected in the following database record: biostudies:S-SCDT-10_103
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 17 authors, 1 keyword, 15 MeSH terms, 3 funders, 61 references.
Cite
This paper
Cao, Z., Zhu, Z., Zeng, P., Mei, F., Wang, D., Xu, J., Xu, Y., Chen, K., Wei, C., Shen, J., Jin, K., Chen, J., Li, Z., Liu, B., Schlüter, D., Huang, J., & Wang, X. (2026). OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation. EMBO molecular medicine, 18(8), 3137-3156. https://
BibTeX
@article{cao2026otub1,
author = {Cao, Zijun and Zhu, Zhenhu and Zeng, Ping and Mei, Fuqi and Wang, Deqi and Xu, Jun and Xu, Yanqi and Chen, Kangmin and Wei, Chushan and Shen, Jiangyun and Jin, Keshuo and Chen, Jiaqing and Li, Zhongding and Liu, Baohua and Schlüter, Dirk and Huang, Jingyong and Wang, Xu},
title = {{OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation}},
journal = {EMBO molecular medicine},
year = {2026},
month = jul,
volume = {18},
number = {8},
pages = {3137--3156},
publisher = {Nature Publishing Group},
issn = {1757-4676},
doi = {10.1038/
url = {https://
pmid = {42393340},
pmcid = {PMC13470327}
}
RIS
TY - JOUR
AU - Cao, Zijun
AU - Zhu, Zhenhu
AU - Zeng, Ping
AU - Mei, Fuqi
AU - Wang, Deqi
AU - Xu, Jun
AU - Xu, Yanqi
AU - Chen, Kangmin
AU - Wei, Chushan
AU - Shen, Jiangyun
AU - Jin, Keshuo
AU - Chen, Jiaqing
AU - Li, Zhongding
AU - Liu, Baohua
AU - Schlüter, Dirk
AU - Huang, Jingyong
AU - Wang, Xu
TI - OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation
T2 - EMBO molecular medicine
J2 - EMBO Mol Med
PY - 2026
DA - 2026/
VL - 18
IS - 8
SP - 3137
EP - 3156
SN - 1757-4676
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "OTUB1 non-canonically inhibits TAB2 ubiquitination to govern microglia-mediated neuroinflammation",
"container-title": "EMBO molecular medicine",
"author": [
{
"family": "Cao",
"given": "Zijun"
},
{
"family": "Zhu",
"given": "Zhenhu"
},
{
"family": "Zeng",
"given": "Ping"
},
{
"family": "Mei",
"given": "Fuqi"
},
{
"family": "Wang",
"given": "Deqi"
},
{
"family": "Xu",
"given": "Jun"
},
{
"family": "Xu",
"given": "Yanqi"
},
{
"family": "Chen",
"given": "Kangmin"
},
{
"family": "Wei",
"given": "Chushan"
},
{
"family": "Shen",
"given": "Jiangyun"
},
{
"family": "Jin",
"given": "Keshuo"
},
{
"family": "Chen",
"given": "Jiaqing"
},
{
"family": "Li",
"given": "Zhongding"
},
{
"family": "Liu",
"given": "Baohua"
},
{
"family": "Schlüter",
"given": "Dirk"
},
{
"family": "Huang",
"given": "Jingyong"
},
{
"family": "Wang",
"given": "Xu"
}
],
"container-title-short":
"volume": "18",
"issue": "8",
"page": "3137-3156",
"DOI": "10.1038/
"PMID": "42393340",
"PMCID": "PMC13470327",
"ISSN": "1757-4676",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
2
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s12951-026-04551-7
- The role of AI-assisted drug repurposing in neurological disorders: a systematic review of validation strategies, challenges and opportunities.Journal: Journal of nanobiotechnologyIn common: NCBI GEO GSE16561, 2 references
- [2] doi:10.1002/jnr.70130
- Pantothenic Acid Protects Neurons After Ischemic Stroke by Targeting ID3 to Restore Action Potential Amplitude.Journal: Journal of neuroscience researchIn common: NCBI GEO GSE16561, mouse, cellular / molecular, 1 reference
- [3] doi:10.1002/advs.77175
- TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: cellular / molecular, 3 references
- [4] doi:10.1007/s10571-026-01710-0
- The Role and Diagnostic Efficacy of the METTL14/
GADD45B m& lt;sup& gt;6& lt;/ sup& gt;A Methylation/ BDNF Regulatory Axis in Acute Ischemic Stroke. Journal: Cellular and molecular neurobiologyIn common: NCBI GEO GSE16561 - [5] doi:10.3389/fmolb.2026.1844734
- Discovery and validation of programmed cell death-associated key biomarker genes in ischemic stroke via ssGSEA/
WGCNA and LASSO-SVM-RFE. Journal: Frontiers in molecular biosciencesIn common: NCBI GEO GSE16561 - [6] doi:10.3389/fphar.2026.1870571
- Tissue-autonomous pharmacological direction: how target expression landscapes convert balanced compounds into tissue-selective agents.Journal: Frontiers in pharmacologyIn common: NCBI GEO GSE16561
- [7] doi:10.1038/s44318-026-00817-w
- The C9orf72/
SMCR8 complex maintains microglial homeostasis via RAB8A-ESCRT-mediated lysosomal repair. Journal: The EMBO journalIn common: mouse, cellular / molecular, 2 references - [8] doi:10.1038/s41467-026-75862-4 [code]
- Targeting m&
lt;sup& gt;6& lt;/ sup& gt;A writer METTL3 with engineered nanovesicles reduces neuroinflammation in vitro and in vivo. Journal: Nature communicationsIn common: mouse, cellular / molecular, 2 references - [9] doi:10.1186/s12974-026-03848-6 [code]
- Iba1 deficiency impairs microglial synaptic remodeling and neuronal survival after axonal injury.Journal: Journal of neuroinflammationIn common: mouse, cellular / molecular, 2 references
- [10] doi:10.1242/dmm.052810
- Fos regulates age-dependent neuroinflammation in a VAPP58S model of amyotrophic lateral sclerosis.Journal: Disease models & mechanismsIn common: cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
